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It was recently noticed that an error had been made in the
research article by Ljuslinder and colleagues [1] published by
Breast Cancer Research in July 2005. The legend of Table 4
was incorrect and should read as featured opposite.
Reference
1. Ljuslinder I, Malmer B, Golovleva I, Thomasson M, Grankvist K,
Höckenström T, Emdin S, Jonsson Y, Hedman H, Henriksson R:
Increased copy number at 3p14 in breast cancer. Breast
Cancer Research 2005, 7:R719-R727.
Correction
Correction: Increased copy number at 3p14 in breast cancer
Ingrid Ljuslinder1, Beatrice Malmer1, Irina Golovleva2, Marcus Thomasson1, Kjell Grankvist3,
Thomas Höckenström4, Stefan Emdin5, Yvonne Jonsson1, Håkan Hedman1 and Roger Henriksson1
1Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden
2Department of Medical Biosciences, Medical and Clinical Genetics, Umeå, Sweden
3Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden
4Department of Pathology, Umeå University, Umeå, Sweden
5Department of Surgical and Perioperative Sciences, Division of Surgery, Umeå University, Sweden
Corresponding author: Ingrid Ljuslinder, ingrid.ljuslinder@onkologi.umu.se
Published: 4 April 2006 Breast Cancer Research 2006, 8:405 (doi:10.1186/bcr1409)
This article is online at http://breast-cancer-research.com/content/8/2/405
© 2006 BioMed Central Ltd
Table 4
EGFR and ERBB2 quantitative RT-PCR mRNA results in eight
patients and matched controls (group B)
Patient number T NN T/NNa
1b
EGFR 4,677 12,493 0.37
ERBB2 24,066 21,817 1.1
2b
EGFR 3,321 14,519 0.22
ERBB2 61,389 6,666 9.2
4
EGFR 20,778 14,842 1.39
ERBB2 9,143 6,742 1.35
5b
EGFR 9,730 15,867 0.61
ERBB2 13,506 3,056 4.41
6
EGFR 1,305 15,871 0.08
ERBB2 10,677 10,080 1.06
7
EGFR 1,024 12,162 0.08
ERBB2 7,639 5,871 1.30
8b
EGFR 4,936 28,111 0.17
ERBB2 17,106 9,263 1.85
9
EGFR 5,540 1,437 3.85
ERBB2 7,330 5,540 1.32
aT/NN: mRNA expression levels of EGFR/ERBB2 in tumour tissue (T)
samples divided by values in in matched non-neoplastic (NN) tissue
samples. As described in the results, at p.9, ratios >1. 2 are regarded
as significant overexpression and ratios <0. 8 are regarded as
significant underexpression in neoplastic tissue compared to non-
neoplastic tissue. bPatients with increased LRIG1 copy number. No
RNA from patient 3 was available for EGFR/ERBB2 analysis.